Nuvalent
NUVL
172 hedge funds and large institutions have $4.98B invested in Nuvalent in 2024 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 72 increasing their positions, 55 reducing their positions, and 32 closing their positions.
301% more call options, than puts
Call options by funds: $51.4M | Put options by funds: $12.8M
31% more repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 55
2.39% more ownership
Funds ownership: 108.56% → 110.95% (+2.4%)
4% more capital invested
Capital invested by funds: $4.78B → $4.98B (+$197M)
4% less funds holding
Funds holding: 180 → 172 (-8)
10% less funds holding in top 10
Funds holding in top 10: 10 → 9 (-1)
22% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 32
Top Buyers
| 1 |
WP
Woodline Partners
San Francisco,
California
|
+$58.4M |
| 2 |
PBA
Paradigm Biocapital Advisors
New York
|
+$28M |
| 3 |
Pictet Asset Management
Carouge,
Switzerland
|
+$26.1M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$25.9M |
| 5 |
BlackRock
New York
|
+$22.4M |
Top Sellers
NUVL Hedge Fund Activity: Q2 2024 in Review
172 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Nuvalent (NUVL) for Q2 2024, worth a combined $4.98B — up 4.1% from $4.78B a quarter earlier.
Sellers outnumbered buyers: 32 funds closed out of NUVL and 25 opened new positions — a net loss of 7 holders — while 55 trimmed existing stakes and 72 added.
The largest buyer was Woodline Partners, adding an estimated $58.4M. The largest seller was Darwin Global Management, exiting entirely with an estimated $108M sold.
- 172 institutional investors held Nuvalent (NUVL) as of Q2 2024, down from 180 in Q1 2024.
- Funds reported $4.98B of Nuvalent stock for Q2 2024, up 4.1% quarter-over-quarter.
- 25 funds opened new Nuvalent positions in Q2 2024 and 32 closed out, a net change of -7 holders.
- The largest Nuvalent buyer in Q2 2024 was Woodline Partners, an estimated $58.4M added.
- The largest Nuvalent seller in Q2 2024 was Darwin Global Management, an estimated $108M sold.
Based on aggregated 13F filings for Q2 2024.